Cancer nanomedicine: Is targeting our target?

Nature Reviews Materials

Volumn 1, Issue 9, 2016, Pages

  Lammers, Twan ^a,b,c   Kiessling, Fabian ^a   Ashford, Marianne ^d   Hennink, Wim ^c   Crommelin, Daan ^c   Strom, Gert ^b,c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85019406563     PISSN: None     EISSN: 20588437     Source Type: Journal    
DOI: 10.1038/natrevmats.2016.69     Document Type: Note

References (5)

1. Torrice, M. Does nanomedicine have a delivery problem? ACS Cent. Sci. 2, 434-437 (2016).
2. Venditto, V.J., Szoka, F.C. Cancer nanomedicines: So many papers and so few drugs! Adv. Drug Deliv. Rev. 65, 80-88 (2013).
3. Wilhelm, S., et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).
4. Lammers, T., Rizzo, L.Y., Storm, G., Kiessling, F. Personalized nanomedicine. Clin. Cancer Res. 18, 4889-4894 (2012).
5. Tietjen, G.T., Saltzman, W.M. Nanomedicine gets personal. Sci. Transl. Med. 7, 314-47 (2015).